Latest News
The memory maker's earnings keep setting records, and its guidance points to another one. The stock sits about 23% below its high anyway.
Via The Motley Fool · August 16, 2026
Rose Nicole Dominique Reich Sapire exercised stock options and withheld shares to cover tax obligations, retaining 15,246 direct shares and 65,520 options, per her latest Form 4.
Via The Motley Fool · August 16, 2026
AI hardware is becoming harder to manufacture, creating a critical opportunity few investors understand. See which companies could capture the upside and which risks could disrupt the thesis.
Via The Motley Fool · August 16, 2026
Google Cloud is Alphabet's fastest-growing division.
Via The Motley Fool · August 16, 2026
There's good news and bad news.
Via The Motley Fool · August 16, 2026
Earnings season continues to give strong results, but that doesn’t mean each stock is rising because of the news.
Via The Motley Fool · August 16, 2026
Dean's liquidation is on the heels of the stock price climbing nearly 65% over the last 12 months.
Via The Motley Fool · August 16, 2026
Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference.
Vance, who has been CEO for about 10 months after previously serving
Via MarketBeat · August 16, 2026
This filing details a non-discretionary tax withholding tied to stock option exercise.
Via The Motley Fool · August 16, 2026
This filing details a non-discretionary sale executed to cover tax withholding from the exercise of vested options.
Via The Motley Fool · August 16, 2026

જેને: જેની ચિંતા હોય.રહેઠાણ એ કોઈ વૈભવી વસ્તુ નથી - તે એક મૂળભૂત અધિકાર છેઇઝરાયલમાં હજારો અપંગ લોકોને દર મહિને એક અશક્ય વાસ્તવિકતાનો સામનો કરવાની ફરજ પડે છ
Via Talk Markets · August 16, 2026
They are fairly risky, but their potential upside is massive.
Via The Motley Fool · August 16, 2026
The chipmaker's valuation is far higher than those of its peers.
Via The Motley Fool · August 16, 2026
Rani Therapeutics (NASDAQ:RANI) outlined its strategy to expand the use of its RaniPill oral biologic-delivery platform through a mix of technology partnerships, selectively licensed product programs and investments in manufacturing capacity.
Chief Executive Officer Talat Imran described the clinic
Via MarketBeat · August 16, 2026
Nvidia and Meta are attacking artificial intelligence from opposite ends. Discover where each moat is strongest, what could weaken it, and why this battle may produce two winners.
Via The Motley Fool · August 16, 2026
AeroVironment stock is facing a major test as top Wall Street analysts remain divided about its future and bottoming signs emerge
Via Benzinga · August 16, 2026
Analog Devices will publish its financial results later this week, with the options market predicting some modest moves.
Via Benzinga · August 16, 2026
You pay a price for those extra years of benefits.
Via The Motley Fool · August 16, 2026
This sale reduced an insider's direct equity holdings by 11%.
Via The Motley Fool · August 16, 2026
A multiple this low usually means the market smells decline -- yet the latest quarter set records.
Via The Motley Fool · August 16, 2026
This sale reduced an insider's direct common stock position by 27%, though a majority of the position remains held through trusts and spousal holdings.
Via The Motley Fool · August 16, 2026
SpaceX went public with an unusually tiny float available for trading. That's about to change in a big way.
Via The Motley Fool · August 16, 2026
Every three months, I go through an exercise that apparently strikes a large portion of the investing public as hopelessly old fashioned. I look at what successful investors are actually buying. I know. Crazy
Via Benzinga · August 16, 2026
Tarr reduced his direct equity stake but retains roughly 268,000 shares valued at $33.7 million.
Via The Motley Fool · August 16, 2026
The right strategy could be a game changer.
Via The Motley Fool · August 16, 2026